335 related articles for article (PubMed ID: 26317792)
21. ZBP-89 and Sp1 contribute to Bak expression in hepatocellular carcinoma cells.
Kong X; Xu P; Cai WJ; Wang HG; Li BB; Huang GL; He ZW; Chen G; Ye CG
BMC Cancer; 2018 Apr; 18(1):419. PubMed ID: 29653560
[TBL] [Abstract][Full Text] [Related]
22. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation.
Zhao Y; Guo Q; Chen J; Hu J; Wang S; Sun Y
Oncol Rep; 2014 Jan; 31(1):358-64. PubMed ID: 24247585
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of long non coding RNA PCAT-1 contributes to cell proliferation, migration and apoptosis in hepatocellular carcinoma.
Wen J; Xu J; Sun Q; Xing C; Yin W
Mol Med Rep; 2016 May; 13(5):4481-6. PubMed ID: 27035680
[TBL] [Abstract][Full Text] [Related]
24. lncRNA HULC promotes the growth of hepatocellular carcinoma cells via stabilizing COX-2 protein.
Xiong H; Li B; He J; Zeng Y; Zhang Y; He F
Biochem Biophys Res Commun; 2017 Aug; 490(3):693-699. PubMed ID: 28634076
[TBL] [Abstract][Full Text] [Related]
25. The long noncoding RNA HULC promotes liver cancer by increasing the expression of the HMGA2 oncogene via sequestration of the microRNA-186.
Wang Y; Chen F; Zhao M; Yang Z; Li J; Zhang S; Zhang W; Ye L; Zhang X
J Biol Chem; 2017 Sep; 292(37):15395-15407. PubMed ID: 28765279
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
Huang MD; Chen WM; Qi FZ; Sun M; Xu TP; Ma P; Shu YQ
Mol Cancer; 2015 Sep; 14():165. PubMed ID: 26336870
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
[TBL] [Abstract][Full Text] [Related]
28. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y
Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454
[TBL] [Abstract][Full Text] [Related]
29. TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth.
Shen J; Lin H; Li G; Jin RA; Shi L; Chen M; Chang C; Cai X
Oncotarget; 2016 May; 7(22):32088-99. PubMed ID: 27050071
[TBL] [Abstract][Full Text] [Related]
30. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
[TBL] [Abstract][Full Text] [Related]
31. The anti-metastatic effect of 8-MOP on hepatocellular carcinoma is potentiated by the down-regulation of bHLH transcription factor DEC1.
Xiong J; Yang H; Luo W; Shan E; Liu J; Zhang F; Xi T; Yang J
Pharmacol Res; 2016 Mar; 105():121-33. PubMed ID: 26808085
[TBL] [Abstract][Full Text] [Related]
32. LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCC.
Ma L; Xu A; Kang L; Cong R; Fan Z; Zhu X; Huo N; Liu W; Xue C; Ji Q; Li W; Chu Z; Kang X; Wang Y; Sun Z; Han Y; Liu H; Gao X; Han J; You H; Zhao C; Xu X
Hepatology; 2021 Dec; 74(6):3213-3234. PubMed ID: 34322883
[TBL] [Abstract][Full Text] [Related]
33. Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.
Hedrick E; Cheng Y; Jin UH; Kim K; Safe S
Oncotarget; 2016 Apr; 7(16):22245-56. PubMed ID: 26967243
[TBL] [Abstract][Full Text] [Related]
34. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
[TBL] [Abstract][Full Text] [Related]
36. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
[TBL] [Abstract][Full Text] [Related]
37. Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention.
Klec C; Gutschner T; Panzitt K; Pichler M
Expert Opin Ther Targets; 2019 Mar; 23(3):177-186. PubMed ID: 30678498
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA 00312 downregulates cyclin B1 and inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo.
Wu J; Zhou X; Fan Y; Cheng X; Lu B; Chen Z
Biochem Biophys Res Commun; 2018 Feb; 497(1):173-180. PubMed ID: 29432732
[TBL] [Abstract][Full Text] [Related]
39. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
[TBL] [Abstract][Full Text] [Related]
40. Long non‑coding RNA AB019562 promotes cell proliferation and metastasis in human hepatocellular carcinoma.
Wu F; Li J; Du X; Zhang W; Lei P; Zhang Q
Mol Med Rep; 2017 Jul; 16(1):69-74. PubMed ID: 28534955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
